Functional validation experiments demonstrated that knockdown of SLC19A1 significantly inhibited cell proliferation, suggesting that SLC19A1 may act as a potential oncogene in the pathogenesis of colorectal cancer. Here, SLC19A1 is linked to colorectal cancer.